Methylarginine targeting chimeras for lysosomal degradation of intracellular proteins

By sjmartinez • October 18, 2024

Seabrook LJ, Franco CN, Loy CA, Osman J, Fredlender C, Zimak J, Campos M, Nguyen ST, Watson RL, Levine SR, Khalil MF, Sumigray K, Trader DJ, Albrecht LV. Methylarginine targeting chimeras for lysosomal degradation of intracellular proteins. Nat Chem Biol. 2024 Oct 16. doi: 10.1038/s41589-024-01741-y. Epub ahead of print. PMID: 39414979.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Effectiveness of Mailed Patient Activation Letters for Blood Pressure Control: A Randomized Quality Improvement Trial

Cheng MKW, Eseigbe MO, Orozco JH, Park S, Modrow MF, Fontil V, Pletcher MJ. Effectiveness of Mailed Patient Activation Letters for Blood Pressure Control: A[...]

Correction: Letter to the Editor: An unspoken contributor to VILI in ARDS-asymmetry of lung injury

Barjaktarevic I, Kuhn B. Correction: Letter to the Editor: An unspoken contributor to VILI in ARDS-asymmetry of lung injury. Intensive Care Med. 2025 Nov 4.[...]

Extracellular iron and the lung microbiome in smoking and COPD

Healy C, Campbell C, Hoffman K, Butler JJ, Opron K, Erb-Downward JR, Zhang WZ, Barjaktarevic I, Han MK, Kaner RJ, Curtis JL, Freeman CM, Barr[...]